Browsing: Neoadjuvant immunotherapy

Top Line: Are induction tremelimumab and durvalumab safe induction therapy in patients planned to receive chemoradiation for locally advanced NSCLC?The…

Top Line: The single-arm phase 2 NADIM trial supported findings from Checkmate 816 and KEYNOTE-671 by demonstrating impressive pathologic complete…